2019
DOI: 10.1002/cam4.2006
|View full text |Cite|
|
Sign up to set email alerts
|

Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence

Abstract: Background The ERBB2 oncogene hypothesis is challenged in hepatocellular carcinoma (HCC) with the conflicting evidences of human epidermal growth factor receptor 2 (HER2) overexpression. HER2 could be a new target as a treatment option for HCC as well as tumor recurrence after surgery. HER2 in HCC biology needs further explorations. Methods Clinical and mRNA data of HCC patients were obtained from TCGA HCC cohort, GSE89377 and GSE115018. Western Blotting and immunohistochemistry were employed to test expressio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
38
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 45 publications
(50 citation statements)
references
References 29 publications
(44 reference statements)
2
38
1
Order By: Relevance
“…However, it is widely perceived that a drug choice based on biomarker analysis could improve the treatment outcome. Key RTK signaling/angiogenesis genes MET, ERBB2, KDR and EGFR, all implicated in HCC [49][50][51][52], negatively correlate with SOCS1, and the first two with SOCS3 as well. Deregulated EGFR and KDR signaling can contribute to Sorafenib resistance in advanced HCC [51,53].…”
Section: Discussionmentioning
confidence: 98%
“…However, it is widely perceived that a drug choice based on biomarker analysis could improve the treatment outcome. Key RTK signaling/angiogenesis genes MET, ERBB2, KDR and EGFR, all implicated in HCC [49][50][51][52], negatively correlate with SOCS1, and the first two with SOCS3 as well. Deregulated EGFR and KDR signaling can contribute to Sorafenib resistance in advanced HCC [51,53].…”
Section: Discussionmentioning
confidence: 98%
“…ERBB2 (also known as HER2) is closely linked to many enzymes, e.g. fatty acid synthase, which play essential regulatory roles in lipid metabolism or lipogenic pathways [75] and its hepatic expression has been identified in liver diseases [76, 77]. Remarkably, the hepatic gene expression of SDCBP has been found differentially expressed in steatotic liver [78].…”
Section: Discussionmentioning
confidence: 99%
“…However, it is widely perceived that drug choice based on biomarker analysis could improve the treatment outcome. Key RTK signaling/angiogenesis genes MET, ERBB2, KDR and EGFR, all implicated in HCC [36,[70][71][72][73], negatively correlate with SOCS1, and the first two with SOCS3 as well. Deregulated EGFR and KDR signaling can contribute to Sorafenib resistance in advanced HCC [72,74].…”
Section: Rtk Signaling and Angiogenesis Pathwaysmentioning
confidence: 99%